Ramsey Falconer, MD
Drew Falconer, MD
Director, Inova Parkinson's & Movement Disorders Center
Associate Professor of Neurology, UVA School of Medicine
Dr. Drew Falconer is board certified in neurology and is a fellowship-trained movement disorders specialist who specializes in advanced care of patients with Parkinson’s disease, essential tremor, and other movement disorders. He serves as an Associate Professor of Neurology at the UVA School of Medicine Inova campus, and is uniquely qualified in the areas of deep brain stimulation (DBS) and botulinum toxin injections. Dr. Falconer speaks nationally on various topics in Movement Disorders and is a respected national educator in Parkinson’s Disease and DBS.
Financial relationships
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:AcordaTopic:ConsultantDate added:03/07/2024Date updated:03/07/2024
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:AmnealTopic:ConsultantDate added:03/07/2024Date updated:03/07/2024
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:AcadiaTopic:ConsultantDate added:03/07/2024Date updated:03/07/2024
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:AbbottTopic:ConsultantDate added:03/07/2024Date updated:03/07/2024
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:AbbvieTopic:ConsultantDate added:03/07/2024Date updated:03/07/2024
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:Kyowa KirinTopic:ConsultantDate added:03/07/2024Date updated:03/07/2024
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:MedtronicTopic:ConsultantDate added:03/07/2024Date updated:03/07/2024
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:MerzTopic:ConsultantDate added:03/07/2024Date updated:03/07/2024
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:NeurocrineTopic:ConsultantDate added:03/07/2024Date updated:03/07/2024
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:SupernusTopic:ConsultantDate added:03/07/2024Date updated:03/07/2024